Z-1619-2020 Class II Terminated

Recalled by The Binding Site Group, Ltd. — Birmingham, N/A

FDA device recall Z-1619-2020 was initiated by The Binding Site Group, Ltd. on Apr 25, 2019 and is designated Class II. Reason for recall: A reagent in C reactive protein kits is not performing to specification and samples with known concentrations less-than-or-equal to 10 mg/L may be affected The recall status is terminated (terminated Apr 27, 2021). Affected quantity: 1 kit.

Recall details

Product Type
Devices
Report Date
Apr 8, 2020
Initiation Date
Apr 25, 2019
Termination Date
Apr 27, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1 kit

Product description

C-Reactive Protein Kit for use on the SPAplus, REF NK044.S.A, Rx only, UDI (01)05051700018456,

Reason for recall

A reagent in C reactive protein kits is not performing to specification and samples with known concentrations less-than-or-equal to 10 mg/L may be affected

Distribution pattern

U.S.: FL

Code information

Lot 455672

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1619-2020
openFDA file date
Nov 19, 2026
Loaded by RegDataLab
Nov 20, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Need the full FDA record for The Binding Site Group, Ltd.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: openFDA record for Z-1619-2020. Report a data issue: hello@regdatalab.com.